Chrome Extension
WeChat Mini Program
Use on ChatGLM

Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination with Trastuzumab Deruxtecan in Patients with HER2 Low/ultra-Low/null Metastatic Breast Cancer

Journal of Clinical Oncology(2024)

Cited 0|Views21
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined